Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108563
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2005-04-15
Brief Title:
VISN 20 Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
VISN 20 Prophylactic Treatment of IFN-Induced Depression in Hepatitis C
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn more about the effects of interferon and ribavirin combination therapy in people with Hepatitis C The specific aims are
To assess how often depressive symptoms occur in patients taking combination alpha interferon plus ribavirin or pegylated interferon plus ribavirin therapy for Hepatitis C when depressive symptoms occur and how severe the depressive symptoms are when they do occur
To identify potential predictors for the development of depressive symptoms
To identify if citalopram an antidepressant medication can prevent or lessen the severity of depressive symptoms brought about by interferon therapy
To assess how often depressive symptoms occur in patients taking combination alpha interferon plus ribavirin or pegylated interferon plus ribavirin therapy for Hepatitis C when depressive symptoms occur and how severe the depressive symptoms are when they do occur
To identify potential predictors for the development of depressive symptoms
To identify if citalopram an antidepressant medication can prevent or lessen the severity of depressive symptoms brought about by interferon therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None